Corebridge Financial’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,454
Closed -$696K 2901
2025
Q1
$696K Sell
22,454
-436
-2% -$14.5K ﹤0.01% 1416
2024
Q4
$722K Sell
22,890
-1,784
-7% -$84.7K ﹤0.01% 1485
2024
Q3
$1.43M Sell
24,674
-291
-1% -$14.3K 0.01% 1187
2024
Q2
$1.01M Buy
+24,965
New +$990K 0.01% 1332

Other funds holding ASTH

Corebridge Financial's ASTH Position: Q2 2025 in Review

Corebridge Financial sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 22,454 shares — an estimated $696K sold.

Corebridge Financial first reported a position in ASTH in Q2 2024 and held it in 4 quarters. The position peaked at $1.43M in Q3 2024. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Corebridge Financial reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 22,454 Astrana Health shares in Q2 2025, an estimated $696K.
  • Corebridge Financial first reported a position in Astrana Health in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Astrana Health position peaked at $1.43M in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.